• The at-home blood collection and micro sampling devices market is anticipated to grow at an annualized rate of 10.7%, till 2031, claims Roots Analysis

    Considering the cost saving potential associated with the use of at-home blood collection and micro sampling devices in diagnostics, the adoption of such products is anticipated to rise further, specifically amidst the COVID-19 pandemic

    For additional details, please visit
    https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
    The at-home blood collection and micro sampling devices market is anticipated to grow at an annualized rate of 10.7%, till 2031, claims Roots Analysis Considering the cost saving potential associated with the use of at-home blood collection and micro sampling devices in diagnostics, the adoption of such products is anticipated to rise further, specifically amidst the COVID-19 pandemic For additional details, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
    At-Home Blood Collection and Micro Sampling Devices Market | Industry Analysis | Market Size | 2030
    At-Home Blood Collection and Micro Sampling Devices Market report features an extensive study of the current market...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • Perks of Regular Diagnostics Tests of Employees in an Organization

    The spread of coronavirus has completely changed one's perspective on taking care of one's health. People started eating healthier, indulging in exercise, and more or less trying to stay fit. Read our article: https://latinosdelmundo.com/article/perks-of-regular-diagnostics-tests-of-employees-in-an-organization
    Perks of Regular Diagnostics Tests of Employees in an Organization The spread of coronavirus has completely changed one's perspective on taking care of one's health. People started eating healthier, indulging in exercise, and more or less trying to stay fit. Read our article: https://latinosdelmundo.com/article/perks-of-regular-diagnostics-tests-of-employees-in-an-organization
    0 Comments 0 Shares
  • The at-home blood collection and micro sampling devices market is anticipated to grow at an annualized rate of 10.7%

    Considering the cost saving potential associated with the use of at-home blood collection and micro sampling devices in diagnostics, the adoption of such products is anticipated to rise further, specifically amidst the COVID-19 pandemic

    For additional details, please visit
    https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
    The at-home blood collection and micro sampling devices market is anticipated to grow at an annualized rate of 10.7% Considering the cost saving potential associated with the use of at-home blood collection and micro sampling devices in diagnostics, the adoption of such products is anticipated to rise further, specifically amidst the COVID-19 pandemic For additional details, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
    At-Home Blood Collection and Micro Sampling Devices Market | Industry Analysis | Market Size | 2030
    At-Home Blood Collection and Micro Sampling Devices Market report features an extensive study of the current market...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million

    Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

    Over time, extensive R&D efforts have resulted in the development of a number of versatile BBB penetration technologies. These technologies have been designed either to externally alter the permeability of the blood csf barrier or augment the BBB penetrating capabilities of compatible pharmacological interventions.

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”

    To request a sample copy / brochure of this report, please visit
    https://www.rootsanalysis.com/reports/310/request-sample.html

    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
     More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS drugs disorders; there are 35+ technology platforms for the development of BBB penetrant drugs
     An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters
     A detailed assessment of the current market landscape of BBB penetrant drugs.
     Identification of contemporary market trends depicted using three schematic representations, which include [A] a tree map representation, [B] a bubble analysis and [C] an informative heptagon representation.
     An insightful competitiveness analysis of BBB penetration technologies, taking into consideration the supplier power and key technology specific information.
     Elaborate profiles of prominent technology developers that are engaged in the development of at least four drugs.
     An analysis of the partnerships that have been established in the domain, in the period between 2014 and 2020.
     An elaborate discussion on the deal structures of various types of technology licensing agreements inked in this domain.
     An analysis of the investments made in the domain, in the period between 2014 and 2020 (till March).
     An in-depth analysis of the various patents that have been filed / granted related to BBB penetration technologies, till November 2019.
     An insightful chessboard analysis highlighting the most preferred / popular drug development strategies / paths adopted by majority of the drug developers (with clinical candidates) in order to progress their lead drug candidates.
     An assessment of the most commonly targeted disorders affecting the central nervous system , shortlisted on the basis of number of BBB penetrant drugs in development.
     A list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s disease that are likely to partner with BBB penetration technology providers.
     A case study highlighting the working principle of the most common approaches that are being employed for the development of BBB penetration technologies.
     An informative analysis of contemporary Google Trends in the time period between 2015 and 2019 (till December) and insights generated from recent news articles related to the BBB, indicating the increasing popularity of this domain.
    A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) :
     Type of Payment Model Adopted
     Upfront payments
     Milestone payments

     Type of Molecule
     Small Molecules
     Biologics

     Target Disease Indication
     Brain Metastases in Breast Cancer
     Glioblastoma Multiforme
     Hunter Syndrome
     Hurler Syndrome

     Leading Technology Platforms
     G®-Technology
     J-Brain Cargo® Technology
     LRP-1 Technology
     Trojan Horse Technology

     Leading Drug Developers
     2-BBB
     Angiochem
     ArmaGen
     JCR Pharmaceuticals

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific

    Transcripts of interviews held with the following senior level representatives of stakeholder companies
     Ram Bhatt (Chief Executive Officer, Chairman and Founder, Innovative California Biosciences International (ICBI))
     Frank S Walsh (Chief Executive Officer and Founder, Ossianix)
     Pieter Gaillard (Chief Executive Officer and Co-Founder, 2-BBB)
     Rob Hutchison (Chief Executive Officer and Chairman, biOasis Technologies)
     Mathias Schmidt (Chief Executive Officer, ArmaGen)
     Mark L Peterson (Chief Operating Officer, Cyclenium Pharma)
     Xavier Rivero (Chief Operating Officer, Sagetis Biotech)
     Carole Desseaux (Head of Clinical Affairs, CarThera)
     Jamal Temsamani (Head of Drug Development, Vect-Horus)
     Kevin Kit Parker (Professor, Wyss Institute, Harvard University)

    Key companies covered in the report
     Angiochem
     ArmaGen
     BioArctic
     Cyclenium Pharma
     Denali Therapeutics
     ICB International
     Iproteos
     JCR Pharmaceuticals
     Lauren Sciences
     Medesis Pharma
     Ossianix
     Vect-Horus

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html or email sales@rootsanalysis.com

    You may also be interested in the following titles:
    1. Novel Coronavirus (Covid-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
    2. DNA-Encoded Libraries: Platforms and Services Market
    3. Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com


    Contact:
    Ben Johnson
    +1 (415) 800 3415
    +44 (122) 391 1091
    Ben.johnson@rootsanalysis.com

    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries Over time, extensive R&D efforts have resulted in the development of a number of versatile BBB penetration technologies. These technologies have been designed either to externally alter the permeability of the blood csf barrier or augment the BBB penetrating capabilities of compatible pharmacological interventions. Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.” To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/310/request-sample.html The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:  More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS drugs disorders; there are 35+ technology platforms for the development of BBB penetrant drugs  An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters  A detailed assessment of the current market landscape of BBB penetrant drugs.  Identification of contemporary market trends depicted using three schematic representations, which include [A] a tree map representation, [B] a bubble analysis and [C] an informative heptagon representation.  An insightful competitiveness analysis of BBB penetration technologies, taking into consideration the supplier power and key technology specific information.  Elaborate profiles of prominent technology developers that are engaged in the development of at least four drugs.  An analysis of the partnerships that have been established in the domain, in the period between 2014 and 2020.  An elaborate discussion on the deal structures of various types of technology licensing agreements inked in this domain.  An analysis of the investments made in the domain, in the period between 2014 and 2020 (till March).  An in-depth analysis of the various patents that have been filed / granted related to BBB penetration technologies, till November 2019.  An insightful chessboard analysis highlighting the most preferred / popular drug development strategies / paths adopted by majority of the drug developers (with clinical candidates) in order to progress their lead drug candidates.  An assessment of the most commonly targeted disorders affecting the central nervous system , shortlisted on the basis of number of BBB penetrant drugs in development.  A list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s disease that are likely to partner with BBB penetration technology providers.  A case study highlighting the working principle of the most common approaches that are being employed for the development of BBB penetration technologies.  An informative analysis of contemporary Google Trends in the time period between 2015 and 2019 (till December) and insights generated from recent news articles related to the BBB, indicating the increasing popularity of this domain. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) :  Type of Payment Model Adopted  Upfront payments  Milestone payments  Type of Molecule  Small Molecules  Biologics  Target Disease Indication  Brain Metastases in Breast Cancer  Glioblastoma Multiforme  Hunter Syndrome  Hurler Syndrome  Leading Technology Platforms  G®-Technology  J-Brain Cargo® Technology  LRP-1 Technology  Trojan Horse Technology  Leading Drug Developers  2-BBB  Angiochem  ArmaGen  JCR Pharmaceuticals  Key Geographical Regions  North America  Europe  Asia-Pacific Transcripts of interviews held with the following senior level representatives of stakeholder companies  Ram Bhatt (Chief Executive Officer, Chairman and Founder, Innovative California Biosciences International (ICBI))  Frank S Walsh (Chief Executive Officer and Founder, Ossianix)  Pieter Gaillard (Chief Executive Officer and Co-Founder, 2-BBB)  Rob Hutchison (Chief Executive Officer and Chairman, biOasis Technologies)  Mathias Schmidt (Chief Executive Officer, ArmaGen)  Mark L Peterson (Chief Operating Officer, Cyclenium Pharma)  Xavier Rivero (Chief Operating Officer, Sagetis Biotech)  Carole Desseaux (Head of Clinical Affairs, CarThera)  Jamal Temsamani (Head of Drug Development, Vect-Horus)  Kevin Kit Parker (Professor, Wyss Institute, Harvard University) Key companies covered in the report  Angiochem  ArmaGen  BioArctic  Cyclenium Pharma  Denali Therapeutics  ICB International  Iproteos  JCR Pharmaceuticals  Lauren Sciences  Medesis Pharma  Ossianix  Vect-Horus For additional details, please visit https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Novel Coronavirus (Covid-19): Preventive Vaccines, Therapeutics and Diagnostics in Development 2. DNA-Encoded Libraries: Platforms and Services Market 3. Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Request Sample - Blood-Brain Barrier (BBB) | Industry Analysis | Market Size | 2030
    Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics Nanoparticle based Approaches)
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%

    The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes

    Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings.

    According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).

    To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html

    Key Market Insights

    Nearly 100 handheld ultrasound imaging devices are presently available / under development
    Close to 85% of the aforementioned scanners use linear and curved / convex transducer arrays. Further, to offer variations in image visualization, about 46% of these devices support more than two modes of imaging, including brightness mode (B-mode), color doppler, motion mode (M-mode), pulsed wave, power doppler and tissue harmonic mode.

    70% of scanners are based on smartphone applications
    Handheld devices using abovementioned type of software are primarily being used for gynecology / obstetrics (32%), urological (21%) and abdomen (12%) scanning. It is worth mentioning that customized software-based scanners are preferred in emergency medicines and hospital operating rooms, owing to their ease of handling .

    Partnership activity has grown at an annualized rate of nearly 43%, between 2016 and 2019
    Majority of the collaborations signed in this domain were reported to be distribution and supply agreements (over 30%). In addition, key value drivers in majority of the agreements were expansion of market reach and incorporation of advanced features in devices.

    Demand for handheld ultrasound scanners is anticipated to grow at a CAGR of 12.1%, between 2020 and 2030
    Presently, over 80,000 units of handheld ultrasound scanners are estimated to be used for diagnostic imaging purpose by physicians. In fact, scanners offered by Butterfly Network, Clarius Mobile Health, Fujifilm, GE Healthcare, Siemens Healthineers and Philips are estimated to cater to more than 80% of the current demand for such devices.

    Handheld ultrasound scanners are estimated to enhance radiologists’ efficiency by ~10%
    Owing to their light-weight, portability and advanced imaging features, these devices allow radiologists to perform more number of scans (as compared to conventional stationary devices) in a single day. In fact, by 2030, we anticipate net annual cost savings of over USD 30 billion to be brought about by the adoption of handheld ultrasound scanners.

    By 2030, North America and Europe are anticipated to capture over 70% of the market opportunity
    The market in European regions is anticipated to grow at a relatively faster rate (12.2%). In terms of end-users, by 2030, hospitals are likely to represent the largest share of the market, followed by ambulatory surgical centers (25%) and specialty clinics (16%).

    To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/319/request-sample.html

    Key Questions Answered
     Who are the leading developers of handheld ultrasound imaging devices?
     What are the key application areas for handheld ultrasound imaging scanners?
     What is the potential usability of handheld ultrasound scanners devices for lung scanning in COVID-19 patients?
     Which partnership models are commonly adopted by stakeholders in this industry?
     What is the annual global demand for handheld ultrasound imaging devices?
     What is the impact of COVID-19 on the demand for handheld ultrasound imaging devices?
     What is the likely cost saving potential associated with the use of handheld ultrasound imaging devices?
     What are the key factors influencing the adoption of handheld ultrasound imaging scanners, among different end-users?
     How is the current and future opportunity likely to be distributed across key market segments?

    The USD 1.1 billion (by 2030) financial opportunity within the handheld ultrasound imaging devices market has been analyzed across the following segments:
     Application Area
     Cardiac Scanning
     Emergency Medicines
     Gynecological / Obstetrics Scanning
     Musculoskeletal Scanning
     Pulmonary Scanning
     Urological Scanning
     Vascular Surgery
     Other Application Areas

     Type of Transducer Array
     Curved
     Endocavity
     Linear
     Phased
     Other Scanners

     Type of Software
     Smartphone Applications
     Customized Software

     End-Users
     Ambulatory Surgical Centers
     Diagnostic Imaging Centers
     Hospitals
     Maternity Clinics
     Specialty Clinics
     Other End-Users

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific and the Rest of the World
    The report features inputs from eminent industry stakeholders, according to whom handheld ultrasound imaging devices are likely to offer lucrative market opportunities for players working in this domain. The report includes detailed transcripts of the discussions held with following industry experts:
     Stefan Maas (Chief Executive Officer, SomaView)
     Anais Concepcion (Director of Content and Campaign Management, EchoNous)
     Zhengzheng Zhu (Oversea Business Development, PeakSonic)

    The research covers brief profiles of key players engaged in the development of handheld ultrasonic diagnostic imaging devices; other popular industry players featured in the report include:
     Aidmax Medical
     Beijing Konted Medical Technology
     Biim Ultrasound
     BreastIT
     CJ Medical
     Guangzhou Top Medical Equipment
     Healcerion
     Interson Medical Instruments
     Somax Systems
     VINNO
     WuHan Youkey Bio-Medical Electronics
     Yor Labs

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html

    You may also be interested in the following titles:
    1. Large Volume Wearable Injectors Market (5th Edition), 2020-2030
    2. Companion Diagnostics Market (2nd Edition), 2019-2030
    3. Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11% The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings. According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19). To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Key Market Insights Nearly 100 handheld ultrasound imaging devices are presently available / under development Close to 85% of the aforementioned scanners use linear and curved / convex transducer arrays. Further, to offer variations in image visualization, about 46% of these devices support more than two modes of imaging, including brightness mode (B-mode), color doppler, motion mode (M-mode), pulsed wave, power doppler and tissue harmonic mode. 70% of scanners are based on smartphone applications Handheld devices using abovementioned type of software are primarily being used for gynecology / obstetrics (32%), urological (21%) and abdomen (12%) scanning. It is worth mentioning that customized software-based scanners are preferred in emergency medicines and hospital operating rooms, owing to their ease of handling . Partnership activity has grown at an annualized rate of nearly 43%, between 2016 and 2019 Majority of the collaborations signed in this domain were reported to be distribution and supply agreements (over 30%). In addition, key value drivers in majority of the agreements were expansion of market reach and incorporation of advanced features in devices. Demand for handheld ultrasound scanners is anticipated to grow at a CAGR of 12.1%, between 2020 and 2030 Presently, over 80,000 units of handheld ultrasound scanners are estimated to be used for diagnostic imaging purpose by physicians. In fact, scanners offered by Butterfly Network, Clarius Mobile Health, Fujifilm, GE Healthcare, Siemens Healthineers and Philips are estimated to cater to more than 80% of the current demand for such devices. Handheld ultrasound scanners are estimated to enhance radiologists’ efficiency by ~10% Owing to their light-weight, portability and advanced imaging features, these devices allow radiologists to perform more number of scans (as compared to conventional stationary devices) in a single day. In fact, by 2030, we anticipate net annual cost savings of over USD 30 billion to be brought about by the adoption of handheld ultrasound scanners. By 2030, North America and Europe are anticipated to capture over 70% of the market opportunity The market in European regions is anticipated to grow at a relatively faster rate (12.2%). In terms of end-users, by 2030, hospitals are likely to represent the largest share of the market, followed by ambulatory surgical centers (25%) and specialty clinics (16%). To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/319/request-sample.html Key Questions Answered  Who are the leading developers of handheld ultrasound imaging devices?  What are the key application areas for handheld ultrasound imaging scanners?  What is the potential usability of handheld ultrasound scanners devices for lung scanning in COVID-19 patients?  Which partnership models are commonly adopted by stakeholders in this industry?  What is the annual global demand for handheld ultrasound imaging devices?  What is the impact of COVID-19 on the demand for handheld ultrasound imaging devices?  What is the likely cost saving potential associated with the use of handheld ultrasound imaging devices?  What are the key factors influencing the adoption of handheld ultrasound imaging scanners, among different end-users?  How is the current and future opportunity likely to be distributed across key market segments? The USD 1.1 billion (by 2030) financial opportunity within the handheld ultrasound imaging devices market has been analyzed across the following segments:  Application Area  Cardiac Scanning  Emergency Medicines  Gynecological / Obstetrics Scanning  Musculoskeletal Scanning  Pulmonary Scanning  Urological Scanning  Vascular Surgery  Other Application Areas  Type of Transducer Array  Curved  Endocavity  Linear  Phased  Other Scanners  Type of Software  Smartphone Applications  Customized Software  End-Users  Ambulatory Surgical Centers  Diagnostic Imaging Centers  Hospitals  Maternity Clinics  Specialty Clinics  Other End-Users  Key Geographical Regions  North America  Europe  Asia-Pacific and the Rest of the World The report features inputs from eminent industry stakeholders, according to whom handheld ultrasound imaging devices are likely to offer lucrative market opportunities for players working in this domain. The report includes detailed transcripts of the discussions held with following industry experts:  Stefan Maas (Chief Executive Officer, SomaView)  Anais Concepcion (Director of Content and Campaign Management, EchoNous)  Zhengzheng Zhu (Oversea Business Development, PeakSonic) The research covers brief profiles of key players engaged in the development of handheld ultrasonic diagnostic imaging devices; other popular industry players featured in the report include:  Aidmax Medical  Beijing Konted Medical Technology  Biim Ultrasound  BreastIT  CJ Medical  Guangzhou Top Medical Equipment  Healcerion  Interson Medical Instruments  Somax Systems  VINNO  WuHan Youkey Bio-Medical Electronics  Yor Labs For additional details, please visit https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html You may also be interested in the following titles: 1. Large Volume Wearable Injectors Market (5th Edition), 2020-2030 2. Companion Diagnostics Market (2nd Edition), 2019-2030 3. Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Handheld Ultrasound Imaging Devices | Industry Analysis | Market Size | 2030
    With enhanced demand for point-of-care imaging solution, the handheld ultrasound imaging devices market is estimated to reach USD 1.2 billion by 2030
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • Asia Pacific Blood Glucose Monitoring Market to Attain Excellent Revenue Growth by 2027

    Market Highlights
    A number of devices for testing the glucose level in the blood are available in the market such as invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), and flash glucose monitoring devices. These devices are designed according to the type of diabetes, which help to identify the blood glucose level within the specified target range and hence help you to track your diet accordingly. Growing awareness regarding the devices in developing countries has fueled the demand for these devices in Asia Pacific region.
    According to the American Diabetes Association, the blood glucose levels for an adult without diabetes is below 100 mg/dl before meals and fasting, and is less than 140 mg/dl two hours after a meal.
    Diabetes is one of the leading causes of premature death and disability. It can be managed effectively if it diagnosed at early stage. However, if left untreated, it can lead to various complications such as heart disease, stroke, kidney damage, and nerve damage.

    Key Players
    Some of the key the players in the market are Abbott Laboratories, Arkay, Inc., Bayer Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd, Sphere Medical, Dexcom, Inc., and LifeScan.

    The blood glucose monitoring devices market is segmented on the basis of product type, application, and end user.
    On the basis of the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.
    On the basis of the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.
    On the basis of the end user, it is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.

    About Market Research Future:
    At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
    Contact:
    Market Research Future®
    99 Hudson Street,5Th Floor
    New York, New York 10013
    United States of America

    Phone:
    +1 628 258 0071(US)
    +44 2035 002 764(UK)
    Email: sales@marketresearchfuture.com
    Website: https://www.marketresearchfuture.com


    Asia Pacific Blood Glucose Monitoring Market to Attain Excellent Revenue Growth by 2027 Market Highlights A number of devices for testing the glucose level in the blood are available in the market such as invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), and flash glucose monitoring devices. These devices are designed according to the type of diabetes, which help to identify the blood glucose level within the specified target range and hence help you to track your diet accordingly. Growing awareness regarding the devices in developing countries has fueled the demand for these devices in Asia Pacific region. According to the American Diabetes Association, the blood glucose levels for an adult without diabetes is below 100 mg/dl before meals and fasting, and is less than 140 mg/dl two hours after a meal. Diabetes is one of the leading causes of premature death and disability. It can be managed effectively if it diagnosed at early stage. However, if left untreated, it can lead to various complications such as heart disease, stroke, kidney damage, and nerve damage. Key Players Some of the key the players in the market are Abbott Laboratories, Arkay, Inc., Bayer Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd, Sphere Medical, Dexcom, Inc., and LifeScan. The blood glucose monitoring devices market is segmented on the basis of product type, application, and end user. On the basis of the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others. On the basis of the application, it is segmented into type 1 diabetes, type 2 diabetes, and others. On the basis of the end user, it is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: Market Research Future® 99 Hudson Street,5Th Floor New York, New York 10013 United States of America Phone: +1 628 258 0071(US) +44 2035 002 764(UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
    Asia Pacific Blood Glucose Monitoring Market Research Report- Forecast to 2027 | MRFR
    Blood Glucose Monitoring Market is expected to grow at a CAGR over 10%from 2017 to 2027, Asia Pacific Blood Glucose Monitoring Industry categorizes the Asia Pacific Market by Product Type, Application and End User | Blood Glucose Monitoring Market | MRFR
    WWW.MARKETRESEARCHFUTURE.COM
    0 Comments 0 Shares
  • Medical Tricorder Market Analysis By Key Players, SWOT Analysis, Growth Factors and Forecast till 2028

    Medical Tricorder Market Analysis
    Scanadu (US), QuantuMDx Group Ltd. (UK), Ibis Biosciences (U.S.), Basil Leaf Technologies (U.S.), and others are some of the prominent players at the forefront of competition in the Medical Tricorder Market and are profiled in MRFR Analysis.
    Global Medical Tricorder Market - Overview
    Medical tricorder is a flourishing sector gaining importance across the world. Medical device used by the consumer to self-diagnose medical condition is known as a medical tricorder. It takes basic vital measurement like heart rate and body temperature within seconds. Major functions of a medical tricorder are to monitor health of a person, summarize patient’s health, diagnose disease and take health measurements. Medical tricorder is helpful for diagnosing a patient’s health condition. Monitoring of health with the help of medical tricorder can be done within seconds. The increase in the demand for medical tricorder among health care providers, helping them to diagnose patient’s health condition, increasing outpatient services in the hospitals, and demand for new technology for diagnoses and monitoring.
    Furthermore, rapid development in technology, increasing government support for research & development, changing lifestyle, and many adverse effects of the present diagnostic methods expected to fuel the market growth during the forecast period. According to findings from the WHO, in 2014, approximately 422 million people suffered from diabetes across the globe.

    Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.
    America is the largest market which is attributed to extensive use of medical tricorder by number of physicians in America. Increasing in patient pool, increase in outpatient services and concentration of major market players of medical tricorder in North America drive this market in America. North America is the largest market whose growth is attributed to an increase in patient pool, and demand for improved technology for diagnosis of ongoing health of a patient drive this market in America. According to the American Diabetes Association, in 2015, approximately 30.3 million Americans which is 9.4% of the American population were suffering from diabetes
    The European market is also growing continuously and slowly catching up with the American market in the near future. Emphasis for early diagnosis of disease condition and awareness regarding the use of tricorder. Extensive research in innovative product development, and adoption of new technologies in healthcare institutes such as hospitals & clinics, research institutes, clinical laboratories, diagnostics center and home care settings. QuantuMDx Group Ltd. is in Europe. It is one of the major market players for medical tricorder, thus favoring the opportunities for research and development activities in the field of medical devices and molecular diagnosis.


    About Market Research Future:
    At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
    Contact:
    Market Research Future®
    99 Hudson Street,5Th Floor
    New York, New York 10013
    United States of America
    Phone:
    +1 628 258 0071(US)
    +44 2035 002 764(UK)
    Email: sales@marketresearchfuture.com
    Website: https://www.marketresearchfuture.com


    Medical Tricorder Market Analysis By Key Players, SWOT Analysis, Growth Factors and Forecast till 2028 Medical Tricorder Market Analysis Scanadu (US), QuantuMDx Group Ltd. (UK), Ibis Biosciences (U.S.), Basil Leaf Technologies (U.S.), and others are some of the prominent players at the forefront of competition in the Medical Tricorder Market and are profiled in MRFR Analysis. Global Medical Tricorder Market - Overview Medical tricorder is a flourishing sector gaining importance across the world. Medical device used by the consumer to self-diagnose medical condition is known as a medical tricorder. It takes basic vital measurement like heart rate and body temperature within seconds. Major functions of a medical tricorder are to monitor health of a person, summarize patient’s health, diagnose disease and take health measurements. Medical tricorder is helpful for diagnosing a patient’s health condition. Monitoring of health with the help of medical tricorder can be done within seconds. The increase in the demand for medical tricorder among health care providers, helping them to diagnose patient’s health condition, increasing outpatient services in the hospitals, and demand for new technology for diagnoses and monitoring. Furthermore, rapid development in technology, increasing government support for research & development, changing lifestyle, and many adverse effects of the present diagnostic methods expected to fuel the market growth during the forecast period. According to findings from the WHO, in 2014, approximately 422 million people suffered from diabetes across the globe. Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa. America is the largest market which is attributed to extensive use of medical tricorder by number of physicians in America. Increasing in patient pool, increase in outpatient services and concentration of major market players of medical tricorder in North America drive this market in America. North America is the largest market whose growth is attributed to an increase in patient pool, and demand for improved technology for diagnosis of ongoing health of a patient drive this market in America. According to the American Diabetes Association, in 2015, approximately 30.3 million Americans which is 9.4% of the American population were suffering from diabetes The European market is also growing continuously and slowly catching up with the American market in the near future. Emphasis for early diagnosis of disease condition and awareness regarding the use of tricorder. Extensive research in innovative product development, and adoption of new technologies in healthcare institutes such as hospitals & clinics, research institutes, clinical laboratories, diagnostics center and home care settings. QuantuMDx Group Ltd. is in Europe. It is one of the major market players for medical tricorder, thus favoring the opportunities for research and development activities in the field of medical devices and molecular diagnosis. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: Market Research Future® 99 Hudson Street,5Th Floor New York, New York 10013 United States of America Phone: +1 628 258 0071(US) +44 2035 002 764(UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
    Medical tricorder Market Research Report Forecast To 2027 | MRFR
    Medical tricorder Market to grow at a CAGR over 6.7% By 2023. Medical Tricorder Market by Type, Application and End user | Medical tricorder Industry
    WWW.MARKETRESEARCHFUTURE.COM
    0 Comments 0 Shares
  • Medical laboratory diagnostics NJ

    With the recent global epidemic, there has been a noticeable increase in public awareness of health and cleanliness. If someone notices any possible symptoms, they rush to the lab to be diagnosed and be tension free from any underlying worries. Medical laboratory diagnostics in NJ, such as Amedix laboratories, are well-equipped labs that provide excellent services and are staffed by highly qualified personnel. Diagnostic services can be painless, straightforward, and cost-effective with exceptional state-of-the-art technology.

    Visit here: https://amedixlaboratory.com/services/
    Medical laboratory diagnostics NJ With the recent global epidemic, there has been a noticeable increase in public awareness of health and cleanliness. If someone notices any possible symptoms, they rush to the lab to be diagnosed and be tension free from any underlying worries. Medical laboratory diagnostics in NJ, such as Amedix laboratories, are well-equipped labs that provide excellent services and are staffed by highly qualified personnel. Diagnostic services can be painless, straightforward, and cost-effective with exceptional state-of-the-art technology. Visit here: https://amedixlaboratory.com/services/
    0 Comments 0 Shares
  • Brooklyn Laboratories

    Brooklyn laboratories can provide diagnoses for accurate and timely reports. Brooklyn labs, located in one of the most developed and well-known cities, are outfitted with cutting-edge technology and can conduct complete diagnostics. The majority of labs are conducted by well-trained medical professionals who understand what needs to be done. Many Brooklyn laboratories, such as Amedix lab, are dependable and deliver precise results with no opportunity for error.

    Visit here: https://amedixlaboratory.com/
    Brooklyn Laboratories Brooklyn laboratories can provide diagnoses for accurate and timely reports. Brooklyn labs, located in one of the most developed and well-known cities, are outfitted with cutting-edge technology and can conduct complete diagnostics. The majority of labs are conducted by well-trained medical professionals who understand what needs to be done. Many Brooklyn laboratories, such as Amedix lab, are dependable and deliver precise results with no opportunity for error. Visit here: https://amedixlaboratory.com/
    0 Comments 0 Shares
  • The teleradiology services market is projected to grow at a CAGR of 16.8% till 2030, claims Roots Analysis

    The growing demand for remote diagnosis and increased workload on radiologists has compelled hospitals / diagnostic centers to adopt teleradiology services, to not only expedite report turnaround process, but also enable cost savings

    Roots Analysis has announced the addition of “Teleradiology Services Market, 2021-2030” market report to its list of offerings.


    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these services over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

     A detailed assessment of the current market landscape of companies engaged in providing teleradiology services.
     An in-depth company competitiveness analysis of teleradiology service providers, taking into consideration various company specific parameters.
     Elaborate profiles of key industry players that are currently engaged in offering teleradiology services.
     An analysis of the partnerships, recent investments, and other recent initiatives taken by various stakeholders engaged in this domain.
     A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging teleradiology players to help unlock an uncontested market.
     An elaborate analysis on the cost saving potential associated with the implementation of teleradiology in interpretation of diagnostic imaging, by taking into consideration several relevant parameters.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

     Type of Image Processed
     CT Scan
     MRI
     Ultrasound
     X-Ray
     Others

     Type of End User
     Hospitals
     Diagnostic / Imaging Centers
     Patients
     Others

     Type of Business Model
     B2B
     B2C

     Key Geographical Regions
     North America
     Europe
     Asia
     Middle East and North Africa
     Latin America
     Rest of the World

    Transcripts of interviews held with the following senior level representatives of stakeholder companies
     Claude Hooton (President and Chief Executive Officer, Nucleushealth)
     Karan Malik (Co-Founder, Eminence Health Solutions)

    To request a sample copy / brochure of this report, please visit this
    https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html


    Key companies covered in the report
     Envision Physician Services
     Everlight Radiology
     Krsnaa Diagnostics
     Medica
     ONRAD
     RAD365
     USARAD Holdings
     vRad
     XMRI.COM

    For more information, please click on the following link:
    https://www.rootsanalysis.com/reports/teraradiology-services-market.html

    Other Recent Offerings
    1. Telemedicine Tools and Software Providers Market: Focus on Remote Patient Monitoring, 2021-2030
    2. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030
    3. Cloud-based Solutions for Drug Discovery, Development and Manufacturing, 2021-2030

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    +44 (122) 391 1091
    Ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    The teleradiology services market is projected to grow at a CAGR of 16.8% till 2030, claims Roots Analysis The growing demand for remote diagnosis and increased workload on radiologists has compelled hospitals / diagnostic centers to adopt teleradiology services, to not only expedite report turnaround process, but also enable cost savings Roots Analysis has announced the addition of “Teleradiology Services Market, 2021-2030” market report to its list of offerings. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these services over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of companies engaged in providing teleradiology services.  An in-depth company competitiveness analysis of teleradiology service providers, taking into consideration various company specific parameters.  Elaborate profiles of key industry players that are currently engaged in offering teleradiology services.  An analysis of the partnerships, recent investments, and other recent initiatives taken by various stakeholders engaged in this domain.  A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging teleradiology players to help unlock an uncontested market.  An elaborate analysis on the cost saving potential associated with the implementation of teleradiology in interpretation of diagnostic imaging, by taking into consideration several relevant parameters.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Image Processed  CT Scan  MRI  Ultrasound  X-Ray  Others  Type of End User  Hospitals  Diagnostic / Imaging Centers  Patients  Others  Type of Business Model  B2B  B2C  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa  Latin America  Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companies  Claude Hooton (President and Chief Executive Officer, Nucleushealth)  Karan Malik (Co-Founder, Eminence Health Solutions) To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html Key companies covered in the report  Envision Physician Services  Everlight Radiology  Krsnaa Diagnostics  Medica  ONRAD  RAD365  USARAD Holdings  vRad  XMRI.COM For more information, please click on the following link: https://www.rootsanalysis.com/reports/teraradiology-services-market.html Other Recent Offerings 1. Telemedicine Tools and Software Providers Market: Focus on Remote Patient Monitoring, 2021-2030 2. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030 3. Cloud-based Solutions for Drug Discovery, Development and Manufacturing, 2021-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    Request Sample - Teleradiology Services Market | Remote Diagnosis | Online Health | Telemedicine | Medical Imaging | Market Size | 2030
    Driven by rising demand for remote patient diagnosis, the teleradiology services market is anticipated to grow at an annualized rate of about 17%, till 2030...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares

No results to show

No results to show

No results to show

Sponsored